Rocket Pharmaceuticals (RCKT) Amortizatization of Intangibles (2016 - 2026)

Rocket Pharmaceuticals has disclosed Amortizatization of Intangibles across 10 years of filings, most recently posting $1.2 million for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $1.2 million, down 43.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 million (down 15.58% YoY), and the FY2025 annual result was $7.3 million, down 9.67% from the prior year.
• Amortizatization of Intangibles came in at $1.2 million for Q1 2026 at Rocket Pharmaceuticals, up from $1.2 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $3.3 million in Q4 2023 to a low of -$577000.0 in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $1.8 million (2024), against an average of $1.6 million.
• Across the five-year window, Amortizatization of Intangibles slumped 197.96% in 2022 and surged 1560.9% in 2023, its largest moves.
• Rocket Pharmaceuticals' Amortizatization of Intangibles stood at $1.1 million in 2022, then surged by 202.96% to $3.3 million in 2023, then tumbled by 62.66% to $1.2 million in 2024, then fell by 1.23% to $1.2 million in 2025, then grew by 1.74% to $1.2 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $1.2 million (Q1 2026), $1.2 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.